Translational insights for cretostimogene grenadenorepvec for BCG-naïve #
BladderCancer#.
@tbivala1 @PennMedicine joins
@UroDocAsh @UTMDAnderson to discuss the translational data from CORE-008 Cohort A, examining cretostimogene grenadenorepvec in high-risk BCG-naive NMIBC with a focus on the five-step versus two-step administration protocol. #
WatchNow# >